Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2001, p. 8276-8288, Vol. 21, No. 24
Department of Immunology, The Scripps
Research Institute, La Jolla, California 92037
Received 28 June 2001/Returned for modification 20 August
2001/Accepted 12 September 2001
We used retrovirus insertion-mediated random mutagenesis to
generate tumor necrosis factor (TNF)-resistant lines from L929 cells.
Using this approach, we discovered that the plasma membrane calcium
ATPase 4 (PMCA4) is required for TNF-induced cell death in L929 cells.
Under basal conditions, PMCA4-deficient (PMCAmut) cells
have a normal phenotype. However, stimulation with TNF induces an
abnormal increase in the intracellular calcium concentration ([Ca2+]i). The substantially elevated
[Ca2+]i caused resistance to TNF-induced cell
death. We found that an increase in the total volume of acidic
compartments (VAC), mainly constituted by lysosomes, is a common event
in cell death caused by a variety of agonists. The increased
[Ca2+]i in PMCAmut cells promoted
lysosome exocytosis, which, at least in part, accounted for the
inhibition of TNF-induced increase in VAC and cell death. Promoting
lysosome exocytosis by calcium inhibited TNF-induced cell death in
wild-type L929 cells, while inhibition of lysosome exocytosis or
increase of VAC by sucrose restored the sensitivity of
PMCAmut cells to TNF-induced cell death. Thus, increase of
the volume of acidic compartment is a part of the cell death process,
and the antideath effect of calcium is mediated, at least in part, by
inhibition of the TNF-induced increase in VAC.
The involvement of calcium in
cell death has been widely reviewed over the last several decades. A
prevalent assumption is that either a low or high intracellular calcium
concentration ([Ca2+]i)
can cause cell death because of the critical role played by calcium in
many physiological processes. However, it has also been shown that
calcium can promote cell survival in a number of systems. For example,
a modest elevation of
[Ca2+]i above normal
resting levels (100 to 150 nM) can promote cell survival in developing
neurons (20).
The proapoptotic effects of calcium can vary across cell types and may
be mediated by different mechanisms. For example, calcium-dependent induction of Nur77 gene expression is essential for T-cell
receptor-induced death in thymocytes (92), whereas
calcium-induced activation of calcineurin has been implicated in
calcium-induced cell death in other cell types (88). The
mechanisms underlying these two types of cell death are relatively
clear. Both Nur77 and calcineurin trigger mitochondrial release of
cytochrome c and subsequent cell death. The former occurs
via direct translocation onto mitochondria (47), and the
latter occurs via dephosphorylation of Bad to initiate mitochondrial
response (88).
On the other hand, very little is known about calcium-mediated
resistance to cell death. Calcineurin has also been suggested to be
involved in calcium-mediated cell protection (52).
Furthermore, p38 mitogen-activated protein kinase-dependent activation
of MEF2C activation may be involved in the calcium-dependent survival
of neurons (53, 63). The mechanism by which calcium
prevents cell death under these conditions is unknown.
It has been well accepted that the principal role of the lysosome is
one of cellular housekeeping. Lysosomes remove damaged macromolecules
from the cellular environment and convert them into reusable products.
However, recent works demonstrated that lysosomal exocytosis occurs in
many cell types, suggesting that this organelle may not be just a final
station of the endocytic pathway but may have other functions (2,
25, 75, 76, 85). At one time, lysosomes were proposed to be
"suicide bags," or prepackaged destruction awaiting a programmed
instruction to strike (14). The suicide bag theory has not
endured because it lacks supporting evidence (50).
However, the possibility that lysosomes play a role in cell death
cannot be excluded, since over the past 40 years, many groups of
investigators have observed alterations in lysosomes during cell death
(14, 51, 60).
Leakage of lysosomes has been observed morphologically in several
models of cell death, including death caused by oxidative stress and by
serum deprivation (7, 65). Autophagy was associated with
death in several different cell types, and inhibition of autophagy
prevented apoptosis induced by withdrawal of nerve growth factor
(36, 62, 91). The role of the lysosome in cell death was
further supported by the observation that various lysosomotropic agents, such as ammonium chloride and chloroquine, can prevent certain
types of cell death, such as that induced by tumor necrosis factor
alpha (TNF) (43, 49, 58). The lysosomal protease cathepsin
D is involved in a number of types of apoptosis, including that induced
by gamma interferon, Fas, and TNF (15, 28, 34, 67, 73).
Although the available data are somewhat limited, there is a growing
body of evidence suggesting that lysosomes actively participate in cell death.
TNF is a proinflammatory cytokine that acts as a mediator of host
defense as well as inflammatory diseases (3, 4). TNF was
originally identified and purified as a factor that leads to rapid
hemorrhagic necrosis of an established tumor (9, 64). It
is now known that TNF can induce cell death in numerous cell types, and
it is widely used to study the mechanisms of cell death. The
morphological characteristics of cells differ markedly among various
TNF-treated cell lines. For example, TNF induces an apoptotic phenotype
(chromatin condensation and cell shrinkage in a nearly or wholly intact
plasma membrane) in MCF-7, KYM, and PC60 tumor cell lines
(19), whereas L929 and WEHI 164 clone 13 cells respond to
TNF with characteristics of necrosis (5, 19).
It is known that death signaling in both apoptotic and necrotic cell
death is initiated by clustering of the TNF receptor-1 and recruitment
of the death domain-containing adapter protein TRADD (1, 19,
33). The subsequent apoptosis of TNF-treated cells is mediated
by activation of caspases and release of cytochrome c from
the mitochondria (48, 82, 83), while the necrotic cell
death of L929 cells is independent of caspases (86).
In an effort to identify genes that mediate the cytolytic effect of
TNF, we have used a random gene disruption approach to generate a
series of L929 mutants that are resistant to TNF-induced cell death.
The gene disrupted in one of the TNF-resistant lines was identified as
PMCA4, a ubiquitously expressed protein that couples the extrusion of
calcium across the plasma membrane with ATP hydrolysis (22,
27). To date, four PMCAs (PMCA1 to -4) have been identified.
PMCA1 and PMCA4 are expressed in almost all tissues, whereas PMCA2 is
expressed primarily in brain and heart and PMCA3 expression is
essentially confined to brain and skeletal muscle. PMCAs were believed
to be Ca2+ pumps that maintain basal levels of
intracellular calcium (22, 27). Here we show that
resistance to cell death in PMCA4-deficient L929 fibroblasts is
mediated by a modest elevation in
[Ca2+]i. We found that an
increase in lysosome volume is a common feature of cells that undergo
either apoptotic or necrotic cell death. We further show that increased
levels of [Ca2+]i in
PMCA4-deficient cells enhanced lysosomal exocytosis. This increase in
[Ca2+]i levels accounts,
at least in part, for the diminished lysosomal response in
PMCA4-deficient cells. The impaired lysosomal response leads, in turn,
to TNF resistance.
Cell culture.
All cell lines were obtained from the American
Type Culture Collection (Rockville, Md.) and cultured under the
recommended conditions. TNF sensitivity was examined in L929 murine
fibrosarcoma cells, which exhibited a spontaneous survival rate of less
than 1 in 106 after 48 h of exposure to TNF
at 100 ng/ml. Stable TNF-resistant cell lines derived from L929 cells
were established either by retroviral infection or by plasmid
transfection with the GenePorter transfection reagent (GTS Inc., San
Diego, Calif.). Stably transfected TNF-resistant clones were selected
in normal growth medium with the addition of either G-418 (1 mg/ml) or
blasticidin S (10 µg/ml) (Invitrogen, Carlsbad, Calif.).
Retroviral vector construction and subcloning.
The pDisrup
retroviral vector was constructed based on the Moloney murine leukemia
virus retroviral vector pLNCX backbone (56). This vector
encodes a neo gene that is driven by the cytomegalovirus (CMV) promoter, but lacks a poly(A) addition signal sequence
(89). Standard recombinant DNA techniques were used in
vector construction and subcloning. The splicing donor and acceptor
sites were designed based on the human adenovirus type 2 major late
mRNA intron sequence. Incorporation of the splicing donor sequence
downstream from the neo coding sequence permitted the
generation of a neo mRNA fused with the downstream exon of a
disrupted gene if viral insertion occurred within an intron. If the
virus inserted within an exon, the expressed neo mRNA should
represent a direct fusion with endogenous exon sequences at the
insertion site. neo mRNA cannot be expressed if the
insertion occurs in a nongene region. Further details of the retroviral
plasmid are available upon request. The PMCA4 cDNA was obtained from
Ernst Carafoli and subcloned into the pcDNA6 expression vector, which
carries blasticidin resistance (Invitrogen, Carlsbad, Calif.).
Retrovirus production and cell infection.
pDisrup
recombinant retroviruses were generated in Phoenix Amphotropic producer
cells using the calcium phosphate method of transfection
(56). Viruses were produced at 32°C, and
virus-containing medium was collected 24 h posttransfection and
filtered through a 0.45-µm filter. L929 cells were plated in six-well
plates at a density of 5 × 105 cells/well.
One round of retroviral infection was performed by replacing medium
with 2 ml of pDisrup virus (containing 4 µg of Polybrene per ml),
followed by centrifugation of the six-well plates at 2,500 rpm for 30 min at 32°C.
3'-RACE.
The portion of the endogenous gene that was fused
with the neo gene was amplified by the 3' rapid
amplification of cDNA ends (RACE) technique. Total RNA was isolated,
and reverse transcription was performed with the primer 5'-CCA GTG
AGC AGA GTG ACG AGG ACT CGA GCT CAA
GC[T]17-3'. A nested PCR was performed
with the resulting reverse transcription product with the following
primers: P1/Q1 (5'-ATG GGC TGA CCG CTT CCT-3' and
5'-CCA GTG AGC AGA GTG ACG-3') and P2/Q2 (5'-GAC GAG
TTC TTC TGA CTA GCT AG-3' and 5'-GAG GAC TCG AGC TCA
AGC-3'). P1 and P2 are located on the neo resistance gene, while Q1 and Q2 are on the anchor sequence of QT. The PCR fragments were subcloned into the TA cloning vector (Invitrogen) and
subjected to DNA sequencing.
Western blot analysis.
Crude membranes were prepared as
described (27) and subjected to sodium dodecyl
sulfate-6% polyacrylamide gel electrophoresis, followed by standard
Western blotting procedures. The monoclonal antibody 5F10 (Affinity
Bioreagents, Inc, Golden, Colo.) was used to detect total PMCA immunoreactivity.
Measurement of intracellular calcium.
Cells were loaded with
4 µg of fluo-3 acetoxymethyl (AM) (Molecular Probes, Inc.,
Eugene, Oreg.) and 10 µg of Fura-Red AM (Molecular Probes, Inc.) per
ml in the presence of 4 mM probenecid (Sigma, St. Louis, Mo.) at 37°C
for 1 h, according to published protocols (61). Flow
cytometry analysis was performed at 488 nm excitation, the fluorescence
of fluo-3 was collected at 520 nm, and Fura-Red emission was collected
at 640 nm. An in situ calibration assay for calcium measurements in
L929 cells was performed as described (37). The
fluo-3/Fura-Red ratio versus calcium concentration was plotted and used
to calculate [Ca2+]i in
each sample as described (37).
Measurement of VAC.
Cells in various stages were harvested
and then incubated at 37°C for 15 min with 100 ng/ml LysoTracker
(Molecular Probes, Inc.) or 5 µg/ml acridine orange (AO) (Sigma, St.
Louis, Mo.). Cells were then washed, pelleted, and resuspended in 1 ml
of phosphate-buffered saline (PBS) for measurement of fluorescence
derived from the aggregated LysoTracker or AO in acidic compartments.
The healthy cells (with intact lysosomes) were gated, and the mean
value of the fluorescence intensity was used as the relative value of
total volume of the acidic compartment (VAC).
Cell viability assay using PI staining plus forward-angle light
scattering.
The integrity of the plasma membrane was assessed by
the ability of cells to exclude propidium iodide (PI) (Sigma, St.
Louis, Mo.). Cells were trypsinized, collected by centrifugation,
washed once with PBS, and resuspended in PBS containing 1 µg/ml PI.
The levels of PI incorporation were quantified by flow cytometry on a
FACScan flow cytometer. Cell size was evaluated by forward-angle light
scatting. PI-negative cells of normal size were considered live cells.
Measurement of lysosme pH.
Double fluorescein- and
tetramethylrhodamine-labeled dextran (FTD) (Molecular Probes) was used
as a ratiometric indicator to study the pH change of lysosomes. L929
cells were labeled with FTD (3 mg/ml) for 30 min and then changed to
FTD-free medium for 60 min. FTD was internalized and selectively
localized in lysosomes (21). The ratio of fluorescein
emission at 520 nm to rhodamine emission at 580 nm was used to
calculate pH. The calibration and calculation of fluorescein
emission-to-rhodamine emission ratio were performed as described
(23).
Measurement of intracellular pH.
2',7'-bis-(2-carboxyethyl)-5-(and -6)-carboxyfluorescein (BCECF)
was used as a ratiometric dye for intracellular pH measurement. Cells
were loaded with 2 µg of BCECF AM per ml. Emission fluorescences at
525 and 640 nm were collected. The calibration and calculation of the
525 nm:640 nm emission ratio were performed as previously described
(11).
Measurement of endocytosis and exocytosis.
The endocytosis
of TNF-treated L929 cells was measured as described (57,
87). Briefly, the cells were treated with TNF for 0.5, 1, 2, 4, 6, or 8 h and then cultured with dextran conjugated with
tetramethylrhodamine (Molecular Probes) (3 mg/ml). The cells were
washed after 30 min, and the uptake of dextran was determined by
fluorescence-activated cell sorting (FACS) analysis. Exocytosis was
measured by monitoring the release of dextran that was taken up into
lysosomes (21). Briefly, cells were labeled with dextran conjugated with tetramethylrhodamine for 30 min. The cells were washed
and incubated in dextran-free medium for an additional hour to allow
all conjugated dextran to be taken up into lysosomes. The cells were
treated with TNF for different periods of time, and the dextran that
was retained inside the cells was determined by FACS analysis
(21).
Transmission electron microscopy.
A standard protocol was
used to prepare the samples for electron microscopy (45).
The experiments were performed by the Core Electron Microscope Facility
of the Scripps Research Institute using a Philips CM-100 electron
microscope. Specific images were recorded photographically using Kodak
SO-163 film.
Electrophoretic mobility shift assay.
For the
electrophoretic mobility shift assay, nuclear extracts of cells were
incubated with a double-stranded, 32P-labeled
oligonucleotide containing an NF- Disruption of PMCA4 gene in L929 cells confers resistance to
TNF-induced cell death.
We used retrovirus insertion-mediated
mutagenesis in L929 fibroblasts coupled with TNF treatment to select
TNF-resistant cell lines that were generated by the mutagenesis. As
described in Materials and Methods, the retroviral vector was designed
so that the neo gene was fused to the sequence of the exon
that was at the 3' end of the viral insertion site. The identities of
the disrupted genes in various TNF-resistant cell lines were determined by 3'-RACE of the fused neo mRNA.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.24.8276-8288.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Resistance to Tumor Necrosis Factor-Induced Cell
Death Mediated by PMCA4 Deficiency

and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-Hexosaminidase activity assay.
Confluent monolayers of
L929 cells in culture dishes were washed with PBS and incubated with
0.5 ml of Dulbecco's modified Eagle's medium in the absence of phenol
red for the indicated times.
N-Acetyl-
-D-glucosaminidase
(
-hexosaminidase) activity in the culture medium and in the cells
was measured as described previously (69).
B binding site as a probe as
described elsewhere (41)
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (51K):
[in a new window]
FIG. 1.
PMCA4 is involved in TNF-induced cell death, and
[Ca2+]i influences TNF sensitivity in L929
cells. (A) The fused mRNA of neo and an endogenous gene
in a TNF-resistant L929 clonal cell line was amplified by 3'-RACE. The
junction sequence of the fused cDNA is shown, which reveals that the
viral insertion occurred at the 5' end of the PMCA4 gene. Amino acid
sequence at the C terminus of neo is shown beneath the
mRNA sequence. The sequence introduced by viral vector is shown in
lowercase. The number in parentheses shows the beginning of the PMCA4
gene relative to its start codon (+1). (B) PMCA protein is reduced in
PMCA4 mutant cells (PMCAmut). An antibody that recognizes
all four PMCA isoforms was used in Western blotting analysis on
membrane protein samples from PMCAmut and parental
wild-type L929 cells (PMCA1 to -4 are each
130 kDa, as indicated by
the arrow). A nonspecific band in the Western blot that shown in the
lower panel indicates equal protein loading. (C) Total RNA was prepared
from PMCAmut and two other clonal cell lines that had viral
insertions in other loci. neo mRNA levels were analyzed
by Northern blot using a 32P-labeled double-stranded
neo probe. A single neo fusion mRNA was
detected in PMCAmut cells, as indicated by the
triangle. The asterisk indicates transcripts driven by
the 5' long terminal repeat, which was detected in all three lines by
the neo probe because it contains antisense sequence of
neo. Arrows show the positions of 28S and 18S rRNA. (D)
Stable cell lines were generated from PMCAmut cells by
transfection with either a wild-type PMCA4 expression vector
(reconstituted) or the empty vector (vector). All three cell lines,
together with parental wild-type L929 cells, were treated with TNF (100 ng/ml), and cell viability was determined by PI exclusion plus cell
size at various time points (see Materials and Methods for details).
The samples were analyzed by flow cytometry (FACScan flow cytometer
[Becton Dickinson]) with CellQuest acquisition and analysis software.
(E) Parental L929, PMCAmut, reconstituted, and vector cells
were treated with TNF for various periods of time as indicated. Live
cells were gated as in panel D, and [Ca2+]i
was measured by fluo-3 and Fura-Red fluorescence ratios. Data are
expressed as average ± standard error of the mean as determined
in triplicate samples.
Impaired dynamic Ca2+ regulation in response to TNF in
PMCAmut cells.
Since PMCA4 functions in maintaining
the basal [Ca2+]i, we
next compared [Ca2+]i in
these various cell lines. Calcium concentration was measured by flow
cytometry using fluo-3/Fura-Red ratios as described (61). Fluo-3 emits fluorescence upon binding to Ca2+
and the fluorescence of simultaneously loaded Fura-Red was used to
normalize dye loading. Under basal conditions in normal growth medium,
[Ca2+]i levels were
identical in parental L929 cells, PMCAmut cells,
PMCA4-reconstituted cells, and vector-transfected cells (Fig. 1E). In
contrast, when the cells were treated with TNF, [Ca2+]i increased by
35 nM in parental and in PMCA4-reconstituted cells, whereas
[Ca2+]i increased by
100 nM in PMCAmut cells and vector-transfected
cells. The higher [Ca2+]i
in PMCA4-deficient cells (Fig. 1E) was correlated with a higher survival rate of these cells after TNF treatment (Fig. 1D), suggesting that the elevation in
[Ca2+]i prevents
TNF-induced cell death.
Increased [Ca2+]i protects against cell
death in L929 cells.
It has been well established that modest
elevations in [Ca2+]i can
prevent cell death in developing neurons (20). The
protective effect of increased
[Ca2+]i has also been
observed in other systems (52, 70). The data presented in
Fig. 1D and 1E suggested that the elevated
[Ca2+]i also protects
L929 cells against TNF-induced death. To further establish whether the
TNF resistance observed in the PMCAmut line
resulted from increases in
[Ca2+]i, we treated
parental L929 cells with TNF in the presence of various concentrations
of either LaCl3, an inhibitor of PMCA
(31), or A23187, a calcium ionophore. Both
LaCl3 and A23187 treatment elevated
[Ca2+]i and enhanced
survival in TNF-treated L929 cells (Fig.
2A and 2B). Optimal protection against
TNF-induced cell death was observed at a
[Ca2+]i of
200 nM
(
100 nM above the basal level) (Fig. 2A and 2B). Similar
[Ca2+]i levels were
observed in PMCAmut cells treated with TNF (Fig.
1E).
|
B (84). To examine whether the deficiency of PMCA4 in L929 cells had a general effect on TNF-induced cellular responses, we compared NF-
B activation in TNF-treated parental and
PMCAmut cells by electrophoretic mobility shift
assay. As shown in Fig. 3A, there was no
detectable difference between parental and
PMCAmut cells in NF-
B activation.
|
Disruption of calcium regulation may affect lysosomal function in
TNF-treated cells.
The effect of the PMCA inhibitor
LaCl3 and the calcium ionophore A23187 on
TNF-induced cell death was compared in cells expressing normal levels
of PMCA4 (parental and reconstituted cells) and cells deficient in
PMCA4 (PMCAmut and vector-transfected
PMCAmut) (Fig. 4A).
When the samples were treated with TNF alone, parental and
reconstituted cells had an average survival rate of less than 20%,
while PMCAmut and vector-transfected
PMCAmut cells had a survival rate of
45%
(Fig. 4A). There is a more than twofold difference in survival rate
between PMCA4-normal and PMCA-deficient cells. However, when the cells
were cotreated with LaCl3 or A23187 and TNF, the
survival rates of PMCA4-normal and -deficient lines became comparable
and increased to
50% (Fig. 4A). The similar survival rate of the
TNF-treated cells of the four lines in the presence of
LaCl3 or A23187 further supported the conclusion
that PMCA4 deficiency and LaCl3 and A23187
affected the same event,
[Ca2+]i.
|
TNF increases lysosome volume, and disruption of PMCA4 gene impairs this effect. We next asked whether lysosomes are involved in TNF resistance that is associated with disruption of the PMCA4 gene in L929 cells. LysoTracker is an acidotropic probe that can be used to stain lysosomes and other types of acidic compartments. AO is a weak basic amine that selectively accumulates in cellular compartments of low internal pH and is also widely used for staining lysosomes (44, 65). Parental L929 and PMCAmut cells were treated with TNF, stained with LysoTracker and AO, and analyzed microscopically.
As shown in Fig. 5A, TNF treatment significantly increased the accumulation of LysoTracker and AO staining in parental L929 cells, but not in PMCAmut cells. This suggests that the TNF resistance observed in PMCAmut cells is related to the lysosomal response. However, we also considered the possibility that the intensity of LysoTracker and AO staining could be affected by a decrease in lysosomal pH. We used dextran-fluorescein staining and flow cytometry to determine lysosomal pH as previously described (21). These experiments showed that the pH of lysosomes was not lowered but rather slightly increased in response to TNF treatment, thereby excluding the possibility that the increase in LysoTracker and AO staining was due to reduced lysosomal pH (data not shown). LysoTracker and AO staining can also be influenced by the number of late endosomes present in the cell because of the relatively low internal pH in these structures. However, TNF treatment for 0.5, 1, 2, 4, 6, or 8 h had no influence on the rate of endocytosis in L929 cells as measured by dextran uptake (data not shown). Thus, the differences in LysoTracker and AO staining after TNF stimulation in PMCAmut versus parental cells is most likely due to a difference in either the number or the size of lysosomes in these cells.
|
Calcium-enhanced lysosomal exocytosis is responsible, at least in part, for lack of TNF-induced increase in VAC in PMCAmut cells. Calcium is known to stimulate lysosomal exocytosis in a number of different cell types, including fibroblasts (2, 68, 69). Therefore, it is possible that increased [Ca2+]i in TNF-stimulated PMCAmut cells promotes lysosome exocytosis. This could impede the increase in lysosomal mass observed in parental cells. To test this hypothesis, we measured lysosomal exocytosis in TNF-treated parental and PMCAmut cells. Dextran can be imported into the cell by endocytosis and retained within lysosomes (21). Thus, pulse-chase experiments can be used to measure the rate of dextran exocytosis.
Lysosomes were loaded with dextran conjugated to tetramethylrhodamine, and the free dextran was then washed away. The cells were incubated for an additional 1 h to allow all conjugated dextran to be taken up into lysosomes (21). Cells were then treated with TNF for various times, between 0 and 24 h, and the retention of conjugated dextran was determined. As shown in Fig. 6A, conjugated dextran was released much more quickly in PMCAmut cells than in parental cells. This is consistent with the hypothesis that PMCAmut cells exhibit increased lysosomal exocytosis.
|
-hexosaminidase in
TNF-treated parental and PMCAmut cells. As
reported by others using different cells (69), a constitutive release of
-hexosaminidase was observed in L929 cells
(Fig. 6B). PMCA4 mutation did not influence the basal level of
-hexosaminidase release. Two hours of TNF treatment increased
-hexosaminidase release in PMCAmut but not
parental cells (Fig. 6B). The
-hexosaminidase release could not be
measured at the later time of TNF treatment because of the spillover of
intracellular components of dead cells. The data shown in Fig. 6A and
6B indicated that the lack of increase in VAC in TNF-treated
PMCAmut cells is due, at least in part, to
increased exocytosis of lysosomes in these cells.
To assess whether the diminished lysosome response observed in
PMCAmut cells is mediated by elevated
[Ca2+]i, we increased
[Ca2+]i by treating cells
with either A23187 or LaCl3. Treating parental L929 cells with A23187 inhibited the TNF-induced increase in VAC (Fig.
6C). PMCAmut cells exhibited a much smaller
increase in VAC in response to TNF, and this response was only slightly
affected by A23187 (Fig. 6C). Similar results were obtained in the
cells treated with LaCl3 (data not shown). Thus,
elevation of [Ca2+]i
clearly causes an inhibition of the lysosomal response.
Lysosomal response and cell death.
To examine the requirement
for the lysosomal response in TNF-induced cell death, we thought to
test whether inhibition or enhancement of the increase in VAC
influenced TNF-induced cell death. TNF-induced increase in VAC in
parental L929 cells was inhibited by A23187 (Fig.
7A, left panel). The levels of the VAC were correlated with rate of cell death (Fig. 7A, right panel). PMCAmut cells already had much less
TNF-induced increase in VAC, and A23187 did not have much effect on VAC
and cell death induced by TNF in PMCAmut cells
(Fig. 7A). These data support the idea that the inhibition of the
lysosomal response diminished TNF-induced cell death.
|
-hexosaminidase, which is a measure of lysosomal exocytosis, in L929
cells (data not shown). The three drugs did not affect L929 cell
viability in 24 h, although jasplakinolide and nocodazole
treatment caused a change in cell morphology. Thus, use of these drugs
may provide useful information regarding the effect of the inhibition
of lysosomal exocytosis on TNF-induced cell death. Cotreatment of
parental L929 cells with TNF and these inhibitors did not significantly
alter VAC (Fig. 7B, top left panel). In contrast, these inhibitors
induced an increase in VAC in TNF-treated
PMCAmut cells (Fig. 7B, bottom left panel).
These data suggest that lysosomal exocytosis in TNF-treated parental
cells is low; hence, the effect of the inhibitors is barely seen. On
the other hand, PMCAmut cells have enhanced
lysosomal exocytosis, and therefore the effect of each of these
inhibitors is readily apparent. None of these drugs influenced
TNF-induced cell death in parental cells (Fig. 7B, top right panel). In
contrast, each of these drugs impaired cell survival in TNF-treated
PMCAmut cells, so that cell death occurred at
a level similar to that seen in the parental line (Fig. 7B, bottom
right panel). These findings further support the idea that lysosomes
are involved in cell death.
It is known that indigestible solutes such as sucrose can cause
lysosome fusion, which results in the formation of large lysosomes called sucrosomes (12, 35, 80). Culturing parental L929 and PMCAmut cells in the presence of 0.03 M
sucrose resulted in a significant increase in VAC; in contrast, 0.03 M
glucose did not have such an effect (Fig. 7C, left panel). Both cell
lines were healthy in either sucrose- or glucose-containing medium. In
a second experiment, we cultured parental and
PMCAmut cells in either sucrose- or
glucose-containing medium for 12 h to permit the formation of
sucrosomes prior to TNF exposure. Incubation in sucrose significantly
impaired the cell survival rate in TNF-treated
PMCAmut cells, whereas incubation in glucose had
no effect on survival rate (Fig. 7C, right panel). The effect of
sucrose on parental cells was much less pronounced (Fig. 7C, right
panel). These data further suggest that the TNF resistance in
PMCAmut cells is related to lysosome function.
Cell death is generally associated with an increase in VAC.
We
next examined lysosomes in several different cell types that were
exposed to various death stimuli. L929 and MCF-7 cells were treated
with TNF; PC12 cells were serum deprived; J774 cells were treated with
oxidized LDL; Jurkat cells were treated with a Fas antibody; and
U937 cells were treated with ceramide. As shown in Fig.
8A, increased LysoTracker staining was
observed in each of the samples exposed to a death stimulus. The
relative VAC is shown in Fig. 8B and 8C. VAC changes varied among the
different cell types. The increase in VAC did not correlate with the
type of cell death (either apoptotic or necrotic), but rather seemed to
be related to whether the cells were adherent or nonadherent. Suspended
cells (Jurkat and U937 cells) exhibited much fewer lysosomal changes
than adherent cells (L929, PC12, J774, and MCF-7 cells), which is
probably due to suspended cells' having less cytosole than adherent
cells. Nevertheless, an increase in VAC is a common event across many,
if not all, cell death processes, including apoptosis and necrosis.
|
| |
DISCUSSION |
|---|
|
|
|---|
Using a random mutagenesis approach, we found that disruption of the PMCA4 gene produced a resistance to TNF-induced cell death in L929 cells (Fig. 1). We further demonstrated that a modest elevation in [Ca2+]i underlies the resistance to TNF-induced cell death in PMCAmut cells (Fig. 1 and 2). The calcium-mediated resistance to cell death appeared to be related to lysosome function (Fig. 4). Increased lysosomal volume is a general characteristic of various cell death processes (Fig. 5 and 8). Calcium-promoted lysosomal exocytosis (Fig. 6 and 7) accounted, at least in part, for the inhibition of TNF-induced increase of lysosome volume observed in PMCAmut, which in turn diminished TNF-induced cell death.
Elevation in [Ca2+]i has
long been known to induce apoptotic or necrotic cell death. Multiple
mechanisms can mediate this prodeath effect of calcium, which has been
studied intensively (59). However, while an antideath
effect of calcium has been reported in a number of different cell
systems (20, 52, 70), this effect of calcium has largely
been neglected (59). Here we provide genetic evidence to
support the hypothesis that calcium does indeed have antideath effects.
The prodeath effects of calcium on cell death vary considerably in
different cell types. The antideath effect of calcium may be similarly
dependent on cell type, as calcium promotes lysosomal exocytosis in
many, but not all, types of cells (2). It has been
reported that Ca2+ concentrations between 1 and 5 µM are optimal for exocytosis of lysosomes in permeabilized cells
(69). The exocytosis of lysosomal content was detected in
our system (intact cells) when the intracellular
Ca2+ concentration was
200 nM. It is possible
that the local concentration of Ca2+ in certain
cell compartments of our cell systems had reached the micromolar range
or that 200 nM Ca2+ is sufficient to promote
lysosomal exocytosis in live cells. Our data did not exclude the
possibility that the inhibition of TNF-induced increase in VAC by
calcium was also mediated at a level of lysosome biogenesis.
The transcription factor MEF2 was recently shown to be important in regulating neuronal survival during differentiation and depolarization (53, 63). p38 mitogen-activated protein kinase also plays a critical role in neuronal survival, since p38 activates MEF2. In contrast to its protective function in neurons, MEF2 promotes apoptosis in T cells. This process is thought to be mediated by enhancing the expression of Nur77 (92). L929 cells had very low levels of MEF2 activity, based on a gel shift assay (data not shown). We did not detect any differences in MEF2 activity between parental and PMCAmut cells or between TNF-stimulated and nonstimulated cells (data not shown). p38 was activated by TNF treatment, but inhibition of p38 kinase activity did not alter TNF-induced cell death in either parental or PMCAmut cells (data not shown). Thus, resistance to TNF-induced cell death in PMCA4-deficient cells is unlikely to be related to the p38-MEF2 pathway.
Activation of caspase 8 plays a key role in TNF-induced apoptosis in a number of different types of cells, including MCF-7 cells (74, 78). However, caspase 8 was not involved in TNF-induced death of L929 cells (86). Thus, the lysosomal response during cell death can occur in the absence of caspase 8 activation. In addition, the intracellular calcium concentration seems to have no effect on caspase 8 activation, since treatment of MCF-7 cells with A23187 did not influence TNF-induced caspase 8 activation (data not shown). There are reports suggesting the existence of both caspase-dependent and caspase-independent death pathways (6, 10, 16, 17, 30, 39, 40, 46, 55, 79). Expression of Bax in mammalian cells caused cell death with typical apoptotic phenotypes. Inhibition of caspases by zVAD prevented the cleavage of nuclear and cytosolic substrates of caspases and DNA fragmentation, but failed to prevent the reduction of mitochondrial membrane potential and production of ROS (90).
Interestingly, cell death in the presence of caspase inhibition was associated with cytoplasmic vacuolation (90), which is likely to be the same lysosomal enlargement observed in our experiments. Overexpression of mammalian Bax imposes a lethal phenotype in both Saccharomyces cerevisiae and Schizosaccharomyces pombe (26, 29, 38, 54). The mechanism by which Bax induces yeast cell death is believed to be similar to that in mammals (93). Yeast cells lack caspases, and their death does not show nuclear fragmentation, but rather massive vacuolization of the cytoplasm (93). This is similar to the morphology of human cells expressing Bax in the presence of a caspase inhibitor (90) and L929 cells that were stimulated with TNF. Thus, the signaling pathway that leads to lysosomal responses may be parallel to the caspase pathway. In support of this possibility, there are a number of reports showing that inhibition of caspases blocked nuclear events of apoptosis but not cell death or only delayed cell death (6, 10, 16, 17, 32, 39, 46, 55).
Mitochondria play an important role in many cell death processes (42). Treating L929 cells with TNF in the presence of the ROS scavenger butylated hydroxyanisole inhibited the increase in VAC (data not shown), suggesting that the lysosomal response is downstream of TNF-induced mitochondrial changes. Since there was no detectable cytochrome c released from the mitochondria of TNF-treated L929 cells (24), cytochrome c released from mitochondria may not be required for the lysosomal enlargement observed in our experiments. However, the involvement of other apoptogenic factors released from mitochondria cannot be excluded.
Since programmed cell death is an ordered process, it is likely that lysosomes were responsible for the self-digestion during the course of cell death. Previous studies have provided a large body of evidence suggesting that lysosomes are involved in cell death processes (7, 15, 36, 62, 65, 67, 91). In surveying the literature, we found a number of studies in which increases in the number and size of lysosomes were actually recorded in many electron photomicrographs of apoptotic or necrotic cells, but unfortunately, most of these results have been overlooked (18, 71, 72, 81). The lack of a thorough evaluation of the general involvement of lysosomes in the cell death program is probably related to the lack of a means to evaluate the overall lysosomal changes in cells. The PMCAmut cell line provided an opportunity for us to evaluate the lysosomal changes that occur during the cell death process and to use VAC as an index for lysosomal change. Our data demonstrate that an increase in VAC is a common event in cell death that occurs in response to diverse stimuli.
Increase of lysosomal volume in processes such as TNF-induced cell death appears to be an execution event, as treatment with A23187 inhibits the increase and can effectively impede cell death after initiation of the apoptotic signal (data not shown). However, in certain cases, lysosomes may be also be involved in the initiation of cell death. Autophagy observed in nerve growth factor-deprived neurons (91) and in tamoxifen-treated MCF-7 cells (8) may represent an initial compensatory response to the absence of a growth signal (13). This may act as both a trigger and an executor of cell death. Translocation of a lysosomal protease, cathepsin B or D, to the cytosol was shown to promote mitochondrial release of cytochrome c and apoptosis (28, 66). Accidental leakage of lysosomes in certain pathological situations or during aging may activate the apoptosis pathway or target other cellular organelles, such as mitochondria, to enhance the death signal (77). This possibility may underlie the observation that lysosome leakage occurs prior to mitochondrial and nuclear events in certain instances of cell death (28, 66).
Taken together, our data suggest a mechanism for the antideath effect of calcium and support the idea that lysosomes are not merely the final station of the endocytic pathway (2). In addition to their housekeeping role, lysosomes can indeed function as suicide bags, as Christian de Duve proposed in the late 1950s (14). Nuclear digestion (DNA fragmentation and nucleus condensation) has been well accepted as an essential event in programmed cell death. Lysosome-mediated cytosolic digestion may be as important as nuclear degradation in the cell death process. The increase in the volume of acidic compartments could be another hallmark of dying cells.
| |
ACKNOWLEDGMENTS |
|---|
We thank Ulf T. Brunk, Sandra L. Schmid, and Bruce Beutler for helpful comments and Janet V. Kuhns for excellent secretarial assistance.
This work was supported by U.S. Public Health Service grant no. AI41637 from the National Institute of Allergy and Infectious Diseases and California Cancer Research Program Subcontract no. 99-00521V-10121.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Immunology IMM-32, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. Phone: (858) 784-8704. Fax: (858) 784-8665. E-mail: jhan{at}scripps.edu.
This is publication no. 14231-IMM from the Department of
Immunology, The Scripps Research Institute, La Jolla, Calif.
Present address: Avigen, Inc., Alameda, CA 94502.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aggarwal, B. B., R. A. Aiyer, D. Pennica, P. W. Gray, and D. V. Goeddel. 1987. Human tumour necrosis factors: structure and receptor interactions. Ciba Found. Symp. 131:39-51[Medline]. |
| 2. | Andrews, N. W. 2000. Regulated secretion of conventional lysosomes. Trends Cell Biol. 10:316-321[CrossRef][Medline]. |
| 3. | Beutler, B., and A. Cerami. 1986. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320:584-588[CrossRef][Medline]. |
| 4. | Beutler, B., and A. Cerami. 1988. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu. Rev. Biochem. 57:505-518[CrossRef][Medline]. |
| 5. | Beyaert, R., and W. Fiers. 1994. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity: what we do understand and what we do not. FEBS Lett. 340:9-16[CrossRef][Medline]. |
| 6. | Bouchon, A., P. H. Krammer, and H. Walczak. 2000. Critical role for mitochondria in B cell receptor-mediated apoptosis. Eur. J. Immunol. 30:69-77[CrossRef][Medline]. |
| 7. | Brunk, U. T., and I. Svensson. 1999. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep. 4:3-11[CrossRef][Medline]. |
| 8. |
Bursch, W.,
A. Ellinger,
H. Kienzl,
L. Torok,
S. Pandey,
M. Sikorska,
R. Walker, and R. S. Hermann.
1996.
Active cell death induced by the antiestrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy.
Carcinogenesis
17:1595-1607 |
| 9. |
Carswell, E. A.,
L. J. Old,
R. L. Kassel,
S. Green,
N. Fiore, and B. Williamson.
1975.
An endotoxin-induced serum factor that causes necrosis of tumors.
Proc. Natl. Acad. Sci. USA
72:3666-3670 |
| 10. | Chi, S., C. Kitanaka, K. Noguchi, T. Mochizuki, Y. Nagashima, M. Shirouzu, H. Fujita, M. Yoshida, W. Chen, A. Asai, M. Himeno, S. Yokoyama, and Y. Kuchino. 1999. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Onc. 18:2281-2290. |
| 11. | Chow, S., and D. Hedley. 1997. Flow cytometric measurement of intracellular pH, p. 9.3.1-9.3.10. In P. Robinson (ed.), Current protocols in cytometry. John Wiley & Sons, Inc., New York, N.Y. |
| 12. | Cohn, Z. A., and B. A. Ehrenreich. 1969. The uptake, storage, and intracellular hydrolysis of carbohydrates by macrophages. J. Exp. Med. 129:201-225[Abstract]. |
| 13. | Cuervo, A. M., and J. F. Dice. 1998. Lysosomes, a meeting point of proteins, chaperones, and proteases. J. Mol. Med. 76:6-12[CrossRef][Medline]. |
| 14. | de Duve, C. 1959. Lysosomes, a new group of cytoplasmic particles in subcellular particles, p. 128-159. In T. Hayashi (ed.), Subcellular particles. The Ronald Press Co., New York, N.Y. |
| 15. | Deiss, L. P., H. Galinka, H. Berissi, O. Cohen, and A. Kimchi. 1996. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15:3861-3870[Medline]. |
| 16. |
Doi, T.,
N. Motoyama,
A. Tokunaga, and T. Watanabe.
1999.
Death signals from the B cell antigen receptor target mitochondria, activating necrotic and apoptotic death cascades in a murine B cell line, WEHI-231.
Int. Immunol.
11:933-941 |
| 17. |
Drenou, B.,
V. Blancheteau,
D. H. Burgess,
R. Fauchet,
D. J. Charron, and N. A. Mooney.
1999.
A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
J. Immunol.
163:4115-4124 |
| 18. | Fernandez-Segura, E., F. J. Canizares, M. A. Cubero, A. Warley, and A. Campos. 1999. Changes in elemental content during apoptotic cell death studied by electron probe X-ray microanalysis. Exp. Cell Res. 253:454-462[CrossRef][Medline]. |
| 19. | Fiers, W., R. Beyaert, W. Declercq, and P. Vandenabeele. 1999. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncology 18:7719-7730. |
| 20. | Franklin, J. L., and E. M. Johnson. 1992. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci. 15:501-508[CrossRef][Medline]. |
| 21. | Galloway, C. J., G. E. Dean, R. Fuchs, and I. Mellman. 1988. Analysis of endosome and lysosome acidification in vitro. Methods Enzymol. 157:601-611[Medline]. |
| 22. | Garcia, M. L., and E. E. Strehler. 1999. Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function. Front. Biosci. 4:D869-D882[Medline]. |
| 23. | Geisow, M. J. 1984. Fluorescein conjugates as indicators of subcellular pH: a critical evaluation. Exp. Cell Res. 150:29-35[CrossRef][Medline]. |
| 24. | Goossens, V., K. De Vos, D. Vercammen, M. Steemans, K. Vancompernolle, W. Fiers, P. Vandenabeele, and J. Grooten. 1999. Redox regulation of TNF signaling. Biofactors 10:145-156[Medline]. |
| 25. | Grondin, G., and A. R. Beaudoin. 1996. Immunocytochemical and cytochemical demonstration of a novel selective lysosomal pathway (SLP) of secretion in the exocrine pancreas. J. Histochem. Cytochem. 44:357-368[Abstract]. |
| 26. |
Gross, A.,
K. Pilcher,
E. Blachly-Dyson,
E. Basso,
J. Jockel,
M. C. Bassik,
S. J. Korsmeyer, and M. Forte.
2000.
Biochemical and genetic analysis of the mitochondrial response of yeast to BAX and BCL-X(L).
Mol. Cell. Biol.
20:3125-3136 |
| 27. | Guerini, D., E. Garcia-Martin, A. Zecca, F. Guidi, and E. Carafoli. 1998. The calcium pump of the plasma membrane: membrane targeting, calcium binding sites, tissue-specific isoform expression. Acta Physiol. Scand. Suppl. 643:265-273[Medline]. |
| 28. | Guicciardi, M. E., J. Deussing, H. Miyoshi, S. F. Bronk, P. A. Svingen, C. Peters, S. H. Kaufmann, and G. J. Gores. 2000. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Investig. 106:1127-1137[Medline]. |
| 29. |
Harris, M. H.,
M. G. Vander Heiden,
S. J. Kron, and C. B. Thompson.
2000.
Role of oxidative phosphorylation in Bax toxicity.
Mol. Cell. Biol.
20:3590-3596 |
| 30. | Henkart, P. A. 1996. ICE family proteases: mediators of all apoptotic cell death? Immunity 4:195-201[CrossRef][Medline]. |
| 31. | Herscher, C. J., and A. F. Rega. 1996. Presteady-state kinetic study of the mechanism of inhibition of the plasma membrane Ca2+-ATPase by lanthanum. Biochemistry 35:14917-14922[CrossRef][Medline]. |
| 32. | Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10:735-744[CrossRef][Medline]. |
| 33. |
Hsu, H.,
J. Xiong, and D. V. Goeddel.
1995.
The TNF receptor 1-asssociated protein TRADD signals cell death and NF- B activation.
Cell
81:495-504[CrossRef][Medline].
|
| 34. | Isahara, K., Y. Ohsawa, S. Kanamori, M. Shibata, S. Waguri, N. Sato, T. Gotow, T. Watanabe, T. Momoi, K. Urase, E. Kominami, and Y. Uchiyama. 1999. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience 91:233-249[CrossRef][Medline]. |
| 35. | Jahraus, A., B. Storrie, G. Griffiths, and M. Desjardins. 1994. Evidence for retrograde traffic between terminal lysosomes and the prelysosomal/late endosome compartment. J. Cell Sci. 107:145-157[Abstract]. |
| 36. | Jia, L., R. R. Dourmashkin, P. D. Allen, A. B. Gray, A. C. Newland, and S. M. Kelsey. 1997. Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br. J. Haematol. 98:673-685[CrossRef][Medline]. |
| 37. | June, C. H., R. Aby, and P. S. Rabinovitch. 1997. Measurement of intracellular calcium ions by flow cytometry, p. 9.8.1-9.8.19. In P. Robinson (ed.), Current protocols in cytometry. John Wiley & Sons, Inc., New York, N.Y. |
| 38. | Jurgensmeier, J. M., S. Krajewski, R. C. Armstrong, G. M. Wilson, T. Oltersdorf, L. C. Fritz, J. C. Reed, and S. Ottilie. 1997. Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe. Mol. Biol. Cell 8:325-339[Abstract]. |
| 39. |
Kawahara, A.,
Y. Ohsawa,
H. Matsumura,
Y. Uchiyama, and S. Nagata.
1998.
Caspase-independent cell killing by Fas-associated protein with death domain.
J. Cell Biol.
143:1353-1360 |
| 40. | Kim, S. O., K. Ono, and J. Han. Apoptosis by pan-caspase inhibitors in lipopolysaccharide-activated macropgages. Am. J. Physiol Lung Cell Mol. Physiol., in press. |
| 41. |
Kravchenko, V. V.,
Z. Pan,
J. Han,
J.-M. Herbert,
R. J. Ulevitch, and R. D. Ye.
1995.
Platelet-activating factor induces NF- B activation through a G protein-coupled pathway.
J. Biol. Chem.
270:14928-14934 |
| 42. | Kroemer, G., and J. C. Reed. 2000. Mitochondrial control of cell death. Nat. Med. 6:513-519[CrossRef][Medline]. |
| 43. | Kull, F. C., and J. M. Besterman. 1990. Drug-induced alterations of tumor necrosis factor-mediated cytotoxicity: discrimination of early versus late stage action. J. Cell Biochem. 42:1-12[CrossRef][Medline]. |
| 44. | Kusuzaki, K., H. Murata, H. Takeshita, S. Hashiguchi, T. Nozaki, K. Emoto, T. Ashihara, and Y. Hirasawa. 2000. Intracellular binding sites of acridine orange in living osteosarcoma cells. Anticancer Res. 20:971-975[Medline]. |
| 45. |
Lang, I. M., and R. R. Schleef.
1996.
Calcium-dependent stabilization of type I plasminogen activator inhibitor within platelet alpha-granules.
J. Biol. Chem.
271:2754-2761 |
| 46. |
Lavoie, J. N.,
M. Nguyen,
R. C. Marcellus,
P. E. Branton, and G. C. Shore.
1998.
E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk.
J. Cell Biol.
140:637-645 |
| 47. |
Li, H.,
S. K. Kolluri,
J. Gu,
M. I. Dawson,
X. Cao,
P. D. Hobbs,
B. Lin,
G. Chen,
J. Lu,
F. Lin,
Z. Xie,
J. A. Fontana,
J. C. Reed, and X. Zhang.
2000.
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3.
Science
289:1159-1164 |
| 48. | Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489[CrossRef][Medline]. |
| 49. |
Liddil, J. D.,
R. T. Dorr, and P. Scuderi.
1989.
Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
Cancer Res.
49:2722-2728 |
| 50. | Lloyd, J. B. 1996. The taxonomy of lysosomes and related structures. Subcell. Biochem. 27:1-13[Medline]. |
| 51. | Lockshin, R. A., and J. Beaulaton. 1981. Cell death: questions for histochemists concerning the causes of the various cytological changes. Histochem. J. 13:659-666[CrossRef][Medline]. |
| 52. |
Lotem, J.,
R. Kama, and L. Sachs.
1999.
Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin.
Proc. Natl. Acad. Sci. USA
96:12016-12020 |
| 53. |
Mao, Z.,
A. Bonni,
F. Xia,
M. Nadal-Vicens, and M. E. Greenberg.
1999.
Neuronal activity-dependent cell survival mediated by transcription factor MEF2.
Science
286:785-790 |
| 54. |
Marzo, I.,
C. Brenner,
N. Zamzami,
J. M. Jurgensmeier,
S. A. Susin,
H. L. Vieira,
M. C. Prevost,
Z. Xie,
S. Matsuyama,
J. C. Reed, and G. Kroemer.
1998.
Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis.
Science
281:2027-2031 |
| 55. | Mateo, V., L. Lagneaux, D. Bron, G. Biron, M. Armant, G. Delespesse, and M. Sarfati. 1999. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat. Med. 5:1277-1284[CrossRef][Medline]. |
| 56. |
Miller, A. D., and C. Buttimore.
1986.
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.
Mol. Cell. Biol.
6:2895-2902 |
| 57. | Mohler, J. L., and Y. Sharief. 1993. Flow cytometric assay of pinocytosis: correlation with membrane ruffling and metastatic potential in the Dunning R-3327 rat prostatic adenocarcinoma model. Cytometry 14:826-831[CrossRef][Medline]. |
| 58. | Monney, L., R. Olivier, I. Otter, B. Jansen, G. G. Poirier, and C. Borner. 1998. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 251:295-303[Medline]. |
| 59. | Nicotera, P., and S. Orrenius. 1998. The role of calcium in apoptosis. Cell Calcium 23:173-180[CrossRef][Medline]. |
| 60. | Nixon, R. A., and A. M. Cataldo. 1993. The lysosomal system in neuronal cell death: a review. Ann. N. Y. Acad. Sci. 679:87-109[Medline]. |
| 61. | Novak, E. J., and P. S. Rabinovitch. 1994. Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3/Fura Red fluorescence ratios. Cytometry 17:135-141[CrossRef][Medline]. |
| 62. | Ohsawa, Y., K. Isahara, S. Kanamori, M. Shibata, S. Kametaka, T. Gotow, T. Watanabe, E. Kominami, and Y. Uchiyama. 1998. An ultrastructural and immunohistochemical study of PC12 cells during apoptosis induced by serum deprivation with special reference to autophagy and lysosomal cathepsins. Arch. Histol. Cytol. 61:395-403[Medline]. |
| 63. |
Okamoto, S.,
D. Krainc,
K. Sherman, and S. A. Lipton.
2000.
Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation.
Proc. Natl. Acad. Sci. USA
97:7561-7566 |
| 64. |
Old, L. J.
1985.
Tumor necrosis factor (TNF).
Science
230:630-632 |
| 65. | Ollinger, K., and U. T. Brunk. 1995. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic. Biol. Med. 19:565-574[CrossRef][Medline]. |
| 66. | Roberg, K., U. Johansson, and K. Ollinger. 1999. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic. Biol. Med. 27:1228-1237[CrossRef][Medline]. |
| 67. | Roberg, K., and K. Ollinger. 1998. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am. J. Pathol. 152:1151-1156[Abstract]. |
| 68. |
Rodriguez, A.,
I. Martinez,
A. Chung,
C. H. Berlot, and N. W. Andrews.
1999.
cAMP regulates Ca2+-dependent exocytosis of lysosomes and lysosome-mediated cell invasion by trypanosomes.
J. Biol. Chem.
274:16754-16759 |
| 69. |
Rodriguez, A.,
P. Webster,
J. Ortego, and N. W. Andrews.
1997.
Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells.
J. Cell Biol.
137:93-104 |
| 70. | Rodriguez-Tarduchy, G., M. Collins, and A. Lopez-Rivas. 1990. Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J. 9:2997-3002[Medline]. |
| 71. |
Schulze-Osthoff, K.,
A. C. Bakker,
B. Vanhaesebroeck,
R. Beyaert,
W. A. Jacob, and W. Fiers.
1992.
Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation.
J. Biol. Chem.
267:5317-5323 |
| 72. | Sesso, A., D. T. Fujiwara, M. Jaeger, R. Jaeger, T. C. Li, M. M. Monteiro, H. Correa, M. A. Ferreira, R. I. Schumacher, J. Belisario, B. Kachar, and E. J. Chen. 1999. Structural elements common to mitosis and apoptosis. Tissue Cell 31:357-371[CrossRef][Medline]. |
| 73. | Shibata, M., S. Kanamori, K. Isahara, Y. Ohsawa, A. Konishi, S. Kametaka, T. Watanabe, S. Ebisu, K. Ishido, E. Kominami, and Y. Uchiyama. 1998. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem. Biophys. Res. Commun. 251:199-203[CrossRef][Medline]. |
| 74. |
Srinivasan, A.,
F. Li,
A. Wong,
L. Kodandapani,
R. J. Smidt,
J. F. Krebs,
L. C. Fritz,
J. C. Wu, and K. J. Tomaselli.
1998.
Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells.
J. Biol. Chem.
273:4523-4529 |
| 75. |
Stinchcombe, J. C., and G. M. Griffiths.
1999.
Regulated secretion from hemopoietic cells.
J. Cell Biol.
147:1-6 |
| 76. | Stinchcombe, J. C., L. J. Page, and G. M. Griffiths. 2000. Secretory lysosome biogenesis in cytotoxic T lymphocytes from normal and Chediak Higashi syndrome patients. Traffic 1:435-444[CrossRef][Medline]. |
| 77. |
Stoka, V.,
B. Turk,
S. L. Schendel,
T. H. Kim,
T. Cirman,
S. J. Snipas,
L. M. Ellerby,
D. Bredesen,
H. Freeze,
M. Abrahamson,
D. Bromme,
S. Krajewski,
J. C. Reed,
X. M. Yin,
V. Turk, and G. S. Salvesen.
2001.
Lysosomal protease pathways to apoptosis: cleavage of bid, not Pro-caspases, is the most likely route.
J. Biol. Chem.
276:3149-3157 |
| 78. | Strasser, A., L. O'Connor, and V. M. Dixit. 2000. Apoptosis signaling. Annu. Rev. Biochem. 69:217-245[CrossRef][Medline]. |
| 79. | Susin, S. A., H. K. Lorenzo, N. Zamzami, I. Marzo, B. E. Snow, G. M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Larochette, D. R. Goodlett, R. Aebersold, D. P. Siderovski, J. M. Penninger, and G. Kroemer. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446[CrossRef][Medline]. |
| 80. | Swanson, J., B. Yirinec, E. Burke, A. Bushnell, and S. C. Silverstein. 1986. Effect of alterations in the size of the vacuolar compartment on pinocytosis in J774.2 macrophages. J. Cell Physiol. 128:195-201[CrossRef][Medline]. |
| 81. |
Takemura, G.,
M. Ohno,
Y. Hayakawa,
J. Misao,
M. Kanoh,
A. Ohno,
Y. Uno,
S. Minatoguchi,
T. Fujiwara, and H. Fujiwara.
1998.
Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction.
Circ. Res.
82:1130-1138 |
| 82. | Tartaglia, L. A., T. M. Ayres, G. H. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853[CrossRef][Medline]. |
| 83. |
Tewari, M., and V. M. Dixit.
1995.
Fas- and tumor necrosis factor-induced apoptosis in inhibited by the poxvirus crmA gene product.
J. Biol. Chem.
270:3255-3260 |
| 84. | Tewari, M., and V. M. Dixit. 1996. Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6:39-44[CrossRef][Medline]. |
| 85. | Tulsiani, D. R., A. Abou-Haila, C. R. Loeser, and B. M. Pereira. 1998. The biological and functional significance of the sperm acrosome and acrosomal enzymes in mammalian fertilization. Exp. Cell Res. 240:151-164[CrossRef][Medline]. |
| 86. |
Vercammen, D.,
R. Beyaert,
G. Denecker,
V. Goossens,
G. Van Loo,
W. Declercq,
J. Grooten,
W. Fiers, and P. Vandenabeele.
1998.
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor.
J. Exp. Med.
187:1477-1485 |
| 87. |
Wang, E.,
J. Michl,
L. M. Pfeffer,
S. C. Silverstein, and I. Tamm.
1984.
Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization.
J. Cell Biol.
98:1328-1341 |
| 88. |
Wang, H. G.,
N. Pathan,
I. M. Ethell,
S. Krajewski,
Y. Yamaguchi,
F. Shibasaki,
F. McKeon,
T. Bobo,
T. F. Franke, and J. C. Reed.
1999.
Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.
Science
284:339-343 |
| 89. | Wang, X., K. Ono, S. O. Kim, V. Kravchenko, S. C. Lin, and J. Han. 2001. Metaxin is required for tumor necrosis factor-induced cell death. EMBO Rep. 2:628-633[CrossRef][Medline]. |
| 90. |
Xiang, J.,
D. T. Chao, and S. J. Korsmeyer.
1996.
BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases.
Proc. Natl. Acad. Sci. USA
93:14559-14563 |
| 91. | Xue, L., G. C. Fletcher, and A. M. Tolkovsky. 1999. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell. Neurosci. 14:180-198[CrossRef][Medline]. |
| 92. |
Youn, H. D.,
L. Sun,
R. Prywes, and J. O. Liu.
1999.
Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2.
Science
286:790-793 |
| 93. | Zha, H., H. A. Fisk, M. P. Yaffe, N. Mahajan, B. Herman, and J. C. Reed. 1996. Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell. Biol. 16:6494-6508[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»